Propofol inhibits stromatoxin-1-sensitive voltage-dependent K

Anesthetic Glucose Insulin Kv channel Pancreatic β-cells Propofol Stromatoxin-1

Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2019
Historique:
received: 23 05 2019
accepted: 04 11 2019
entrez: 12 12 2019
pubmed: 12 12 2019
medline: 12 12 2019
Statut: epublish

Résumé

Proper glycemic control is an important goal of critical care medicine, including perioperative patient care that can influence patients' prognosis. Insulin secretion from pancreatic β-cells is generally assumed to play a critical role in glycemic control in response to an elevated blood glucose concentration. Many animal and human studies have demonstrated that perioperative drugs, including volatile anesthetics, have an impact on glucose-stimulated insulin secretion (GSIS). However, the effects of the intravenous anesthetic propofol on glucose metabolism and insulin sensitivity are largely unknown at present. The effect of propofol on insulin secretion under low glucose or high glucose was examined in mouse MIN6 cells, rat INS-1 cells, and mouse pancreatic β-cells/islets. Cellular oxygen or energy metabolism was measured by Extracellular Flux Analyzer. Expression of glucose transporter 2 (GLUT2), potassium channels, and insulin mRNA was assessed by We showed that propofol, at clinically relevant doses, facilitates insulin secretion under low glucose conditions and GSIS in MIN6, INS-1 cells, and pancreatic β-cells/islets. Propofol did not affect intracellular ATP or ADP concentrations and cellular oxygen or energy metabolism. The mRNA expression of GLUT2 and channels including the voltage-dependent calcium channels Cav1.2, Kir6.2, and SUR1 subunit of K Our data support the hypothesis that glucose induces membrane depolarization at the distal site, leading to K

Sections du résumé

BACKGROUND BACKGROUND
Proper glycemic control is an important goal of critical care medicine, including perioperative patient care that can influence patients' prognosis. Insulin secretion from pancreatic β-cells is generally assumed to play a critical role in glycemic control in response to an elevated blood glucose concentration. Many animal and human studies have demonstrated that perioperative drugs, including volatile anesthetics, have an impact on glucose-stimulated insulin secretion (GSIS). However, the effects of the intravenous anesthetic propofol on glucose metabolism and insulin sensitivity are largely unknown at present.
METHODS METHODS
The effect of propofol on insulin secretion under low glucose or high glucose was examined in mouse MIN6 cells, rat INS-1 cells, and mouse pancreatic β-cells/islets. Cellular oxygen or energy metabolism was measured by Extracellular Flux Analyzer. Expression of glucose transporter 2 (GLUT2), potassium channels, and insulin mRNA was assessed by
RESULTS RESULTS
We showed that propofol, at clinically relevant doses, facilitates insulin secretion under low glucose conditions and GSIS in MIN6, INS-1 cells, and pancreatic β-cells/islets. Propofol did not affect intracellular ATP or ADP concentrations and cellular oxygen or energy metabolism. The mRNA expression of GLUT2 and channels including the voltage-dependent calcium channels Cav1.2, Kir6.2, and SUR1 subunit of K
CONCLUSIONS CONCLUSIONS
Our data support the hypothesis that glucose induces membrane depolarization at the distal site, leading to K

Identifiants

pubmed: 31824770
doi: 10.7717/peerj.8157
pii: 8157
pmc: PMC6894434
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e8157

Informations de copyright

©2019 Kusunoki et al.

Déclaration de conflit d'intérêts

The authors declare there are no competing interests.

Références

Anesthesiology. 1989 Aug;71(2):260-77
pubmed: 2667401
Biosci Trends. 2014 Jun;8(3):155-62
pubmed: 25030850
BMC Anesthesiol. 2016 Oct 24;16(1):104
pubmed: 27776485
Anesth Analg. 2007 Jan;104(1):4-6
pubmed: 17179236
PLoS One. 2011;6(12):e29378
pubmed: 22216265
Brain Res. 2006 Jun 22;1096(1):85-96
pubmed: 16716270
J Anesth. 2007;21(4):472-9
pubmed: 18008114
FASEB J. 2019 Mar;33(3):3968-3984
pubmed: 30509117
J Cell Physiol. 2019 Jan 28;:null
pubmed: 30693506
Diabetes. 1967 Jan;16(1):35-9
pubmed: 5333500
News Physiol Sci. 2000 Apr;15:72-77
pubmed: 11390882
Biochem Biophys Res Commun. 2013 Feb 1;431(1):81-5
pubmed: 23274498
Pflugers Arch. 2016 Jul;468(7):1171-1181
pubmed: 26965147
Eur J Pharm Sci. 2010 Jan 31;39(1-3):97-102
pubmed: 19897032
J Biol Chem. 2010 Nov 5;285(45):34781-92
pubmed: 20826794
J Clin Pharmacol. 2011 May;51(5):719-30
pubmed: 20547772
Diabetologia. 2012 Aug;55(8):2096-108
pubmed: 22555472
Biochem Biophys Res Commun. 2004 Oct 8;323(1):323-31
pubmed: 15351740
Vet Sci. 2018 Apr 20;5(2):null
pubmed: 29677106
Anesthesiology. 2015 Feb;122(2):343-52
pubmed: 25296107
Sci Rep. 2016 Sep 29;6:34424
pubmed: 27680676
Endocrinology. 1990 Jul;127(1):126-32
pubmed: 2163307
Diabetologia. 2006 Apr;49(4):697-705
pubmed: 16447058
EBioMedicine. 2018 Apr;30:273-282
pubmed: 29606630
Anesthesiology. 2009 Nov;111(5):1044-51
pubmed: 19809283
Anesthesiology. 1997 Mar;86(3):670-5
pubmed: 9066334
Endocrinology. 1992 Jan;130(1):167-78
pubmed: 1370150
Anesthesiology. 2004 Feb;100(2):338-46
pubmed: 14739809
J Biol Chem. 2009 Oct 30;284(44):30441-52
pubmed: 19690348
Eur J Pharmacol. 2009 Mar 1;605(1-3):1-8
pubmed: 19248246
Pflugers Arch. 2015 Sep;467(9):2011-20
pubmed: 25301522
Neurosci Lett. 2016 Mar 11;616:93-7
pubmed: 26828304
Am J Physiol. 1995 Nov;269(5 Pt 1):E897-902
pubmed: 7491941
Anesth Analg. 2013 Sep;117(3):627-33
pubmed: 23868888
Diabetologia. 1997 May;40(5):487-95
pubmed: 9165215
Am J Physiol Regul Integr Comp Physiol. 2010 Jul;299(1):R177-84
pubmed: 20393158
Mol Pharmacol. 2002 Jul;62(1):48-57
pubmed: 12065754
Neurosci Bull. 2018 Oct;34(5):887-900
pubmed: 29948841
PeerJ. 2015 Dec 10;3:e1498
pubmed: 26713247
Anesth Analg. 1994 May;78(5):955-60
pubmed: 8160997
Endocrinology. 1991 Nov;129(5):2521-9
pubmed: 1682137
Endocrinology. 2014 Oct;155(10):3757-68
pubmed: 24932805
Diabetologia. 1993 Nov;36(11):1139-45
pubmed: 8270128
Clin Exp Pharmacol Physiol. 2018 Dec;45(12):1257-1264
pubmed: 30003581
Am J Physiol Cell Physiol. 2007 Oct;293(4):C1319-26
pubmed: 17699638
Anesth Analg. 2015 Feb;120(2):329-40
pubmed: 25437926
PLoS One. 2018 Feb 15;13(2):e0192796
pubmed: 29447230
J Med Primatol. 2014 Aug;43(4):242-6
pubmed: 24814617
Sci Rep. 2018 Jun 12;8(1):8987
pubmed: 29895831
J Biol Chem. 2002 Nov 22;277(47):44938-45
pubmed: 12270920
Anesth Analg. 2009 Nov;109(5):1479-85
pubmed: 19843785
Life Sci. 2011 Jan 3;88(1-2):96-103
pubmed: 21056586
J Clin Invest. 2005 Aug;115(8):2047-58
pubmed: 16075046
Anesthesiology. 2009 Feb;110(2):408-21
pubmed: 19194167
J Biol Chem. 1994 Nov 11;269(45):27787-90
pubmed: 7961701
Endocr J. 2011;58(12):1021-8
pubmed: 21785227
Anesthesiology. 2002 Dec;97(6):1363-70
pubmed: 12459660
Anesth Analg. 2012 Jan;114(1):110-6
pubmed: 22127813

Auteurs

Munenori Kusunoki (M)

Department of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Mikio Hayashi (M)

Department of Cell Physiology, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Tomohiro Shoji (T)

Department of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Takeo Uba (T)

Department of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Hiromasa Tanaka (H)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Chisato Sumi (C)

Department of Anesthesiology, Kansai Medical University, Hirakata, Japan.
Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Yoshiyuki Matsuo (Y)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Kiichi Hirota (K)

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.

Classifications MeSH